Sara Gutiérrez‐Enríquez

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez et al. · Annals of Oncology · 2018 · 427 citations · Full text

Medicine, Molecular Biology, Oncology +17

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara et al. · EMBO Molecular Medicine · 2018 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +9

A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA

Federica Gemignani, Vı́ctor Moreno, Stefano Landi et al. · Oncogene · 2003 · 219 citations

Medicine, Genetics, Molecular Genetics +16

Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores

Julie Lecarpentier, Valentina Silvestri, Karoline Kuchenbaecker et al. · Journal of Clinical Oncology · 2017 · 181 citations · Full text

Medicine, Genetics, Oncology +17

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 152 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17